Sponsored By

Is J&J Losing Patent Dispute?

A federal judge in Delaware failed to throw out a jury's verdict that the company's Cypher stent infringed on a Boston Scientific patent that covers drug coatings. The New York Times reports that this move goes against the strategy of J&J's lawyers, who were trying to convince the judge that since Cypher was linked to blood clots in clinical studies, it must fall outside the safety profile of Boston Scientific's patent.